The degree of CD4+ T cell proliferation achieved in response to Twist peptide after treatment with MVA-TWIST/TRICOM was very similar between tumor bearing and non-tumor bearing animals, however, the degree of background response was much higher in non-tumor bearing mice (Figures 2A and 3A). The gene discussed is CD4; the disease is neoplasm.